A Phase 3 Study in India to Describe the Safety and Immunogenicity of RSVpreF

RSVpreFOngoingRecruitingPhase 3Open NCT07653100 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…